ICU Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,231	2,382	2,259	2,280	1,316
Revenue Growth (YoY)	-6.33%	5.44%	-0.92%	73.21%	3.56%
Cost of Revenue	1,409	1,557	1,519	1,582	824.82
Gross Profit	822.04	824.78	739.87	697.76	491.49
Selling, General & Admin	625.21	638.76	606.69	608.35	302.58
Research & Development	87.5	88.62	85.34	92.98	47.5
Other Operating Expenses	66.51	54.44	25.01	39.33	18.16
Total Operating Expenses	779.21	781.82	717.05	740.66	368.25
Operating Income	42.83	42.96	22.83	-42.9	123.25
Total Non-Operating Income (Expense)	-39.66	-108.98	-101.12	-71.51	-0.06
Pretax Income	4.36	-66.01	-78.3	-114.41	123.19
Provision for Income Taxes	2.44	51.68	-48.64	-40.12	20.05
Net Income	1.92	-117.69	-29.66	-74.29	103.14
Net Income to Common	1.92	-117.69	-29.66	-74.29	103.14
Net Income Growth	-	-	-	-	18.72%
Shares Outstanding (Basic)	25	24	24	24	21
Shares Outstanding (Diluted)	25	24	24	24	22
Shares Change (YoY)	2.12%	1.23%	0.93%	9.58%	0.88%
EPS (Basic)	0.03	-4.83	-1.23	-3.11	4.86
EPS (Diluted)	0.03	-4.83	-1.23	-3.11	4.74
EPS Growth	-	-	-	-	17.91%
Free Cash Flow	91.8	124.66	82.31	-152.44	199
Free Cash Flow Growth	-26.36%	51.46%	-	-	52.20%
Free Cash Flow Per Share	3.69	5.11	3.42	-6.39	9.14
Gross Margin	36.84%	34.62%	32.75%	30.60%	37.34%
Operating Margin	1.92%	1.80%	1.01%	-1.88%	9.36%
Profit Margin	0.09%	-4.94%	-1.31%	-3.26%	7.84%
FCF Margin	4.11%	5.23%	3.64%	-6.69%	15.12%
EBITDA	243.57	262.48	251.6	192.25	212.94
EBITDA Margin	10.92%	11.02%	11.14%	8.43%	16.18%
EBIT	42.83	42.96	22.83	-42.9	123.25
EBIT Margin	1.92%	1.80%	1.01%	-1.88%	9.36%
Effective Tax Rate	55.92%	-78.28%	62.13%	35.07%	16.28%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q